Black Patients Less Likely to Receive Novel Agents as First-Line CLL Therapy
Investigators revealed unequal access to novel agents when comparing Black and White patients with CLL.
Investigators revealed unequal access to novel agents when comparing Black and White patients with CLL.
The disparity was driven by patients aged 18-29 years.
Cancer death rates are 19% higher among Black men than among White men.
Researchers sought to determine whether there are disparities by race/ethnicity and socioeconomic status in survival outcomes of children with ALL.
A prospective study sought to determine the significance of race on the risk of developing lymphedema and disease severity in women with breast cancer.
Among men with Medicare coverage, Hispanic men had a significant 37% decreased risk for death compared with both non-Hispanic White men and Black men, a study found.
Between 2015 and 2019, Black and Hispanic patients were underrepresented in trials of colorectal, lung, and prostate cancer.
Unemployed adults were less likely to be up to date on screening for cervical, breast, colorectal, and prostate cancer.
The USPSTF intends to consider opportunities to reduce inequities when selecting new preventive care topics and prioritizing current topics.
Most oncologists surveyed reported that Black women encounter more barriers to genetic counseling and testing.